Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  671 results for ""Benzoates""

Your Filters

Subject : pyrazoles
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The long-term efficacy of eltrombopag in children with immune thrombocytopenia.

  • Authors : Yang L; Department of Hematology, Kunming Children's Hospital, No.288 Qian Xin Road, Kunming, 650228, China.; Sang BH

Subjects: Pyrazoles*/Pyrazoles*/Pyrazoles*/therapeutic use ; Pyrazoles*/Pyrazoles*/Pyrazoles*/adverse effects ; Hydrazines*/Hydrazines*/Hydrazines*/therapeutic use

  • Source: Annals of hematology [Ann Hematol] 2024 Aug; Vol. 103 (8), pp. 2721-2727. Date of Electronic Publication: 2024 Jun 25.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy, Safety, and Population Pharmacokinetics of Eltrombopag in Children with Different Severities of Aplastic Anemia.

  • Authors : Zhang W; Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.; Chang LX

Subjects: Benzoates*/Benzoates*/Benzoates*/pharmacokinetics ; Benzoates*/Benzoates*/Benzoates*/adverse effects ; Benzoates*/Benzoates*/Benzoates*/therapeutic use

  • Source: Journal of clinical pharmacology [J Clin Pharmacol] 2024 Aug; Vol. 64 (8), pp. 932-943. Date of Electronic Publication: 2024 Mar 18.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604

Record details

Read More Add to Saved list
×
Academic Journal

Avatrombopag as alternative therapy for severe aplastic anemia patients who are intolerant or unresponsive to eltrombopag.

  • Authors : Zhang T; Department of Hematology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.; Yu Q

Subjects: Anemia, Aplastic*/Anemia, Aplastic*/Anemia, Aplastic*/drug therapy ; Anemia, Aplastic*/Anemia, Aplastic*/Anemia, Aplastic*/therapy ; Benzoates*/Benzoates*/Benzoates*/therapeutic use

  • Source: Frontiers in immunology [Front Immunol] 2024 Jul 24; Vol. 15, pp. 1393829. Date of Electronic Publication: 2024 Jul 24 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial.

  • Authors : Mei H; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1277 Jiefang Avenue, Wuhan, Hubei, China.; Liu X

Subjects: Pyrazoles*/Pyrazoles*/Pyrazoles*/therapeutic use ; Pyrazoles*/Pyrazoles*/Pyrazoles*/adverse effects ; Pyrazoles*/Pyrazoles*/Pyrazoles*/administration & dosage

  • Source: Annals of hematology [Ann Hematol] 2024 Jul; Vol. 103 (7), pp. 2273-2281. Date of Electronic Publication: 2024 Jun 06.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence.

  • Authors : Li X; Soochow Hopes Hematonosis Hospital, Suzhou, Jiangsu, China.; Shangguan X

Subjects: Anemia, Aplastic*/Anemia, Aplastic*/Anemia, Aplastic*/drug therapy ; Anemia, Aplastic*/Anemia, Aplastic*/Anemia, Aplastic*/mortality ; Benzoates*/Benzoates*/Benzoates*/therapeutic use

  • Source: Annals of hematology [Ann Hematol] 2024 Sep; Vol. 103 (9), pp. 3483-3491. Date of Electronic Publication: 2024 Aug 01.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Quality by design-aided acid-free synthesis of self P, N, S-doped black seed-derived carbon quantum dots for application as a nanosensor for eltrombopag environmental and bioanalysis and pharmacokinetic assay.

  • Authors : Abd Elhaleem SM; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Mansoura University, 35516, Mansoura, Egypt.; Belal F

Subjects: Quantum Dots*/Quantum Dots*/Quantum Dots*/chemistry ; Carbon*/Carbon*/Carbon*/chemistry ; Pyrazoles*/Pyrazoles*/Pyrazoles*/chemistry

  • Source: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2024 Oct 15; Vol. 319, pp. 124495. Date of Electronic Publication: Publisher: Elsevier Country of Publication: England NLM ID: 9602533 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3557

Record details

Read More Add to Saved list
×
Academic Journal

Molecular insights on Eltrombopag: potential mitogen stimulants, angiogenesis, and therapeutic radioprotectant through TPO-R activation.

  • Authors : Subbarayan R; Centre for Advanced Biotherapeutics and Regenerative Medicine, Research-FAHS, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, India.; Srinivasan D

Subjects: Pyrazoles*/Pyrazoles*/Pyrazoles*/pharmacology ; Benzoates*/Benzoates*/Benzoates*/pharmacology ; Receptors, Thrombopoietin*/Receptors, Thrombopoietin*/Receptors, Thrombopoietin*/metabolism

  • Source: Platelets [Platelets] 2024 Dec; Vol. 35 (1), pp. 2359028. Date of Electronic Publication: 2024 Jun 04.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9208117 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Report

CD3 + TCRαβ/CD19 + -depleted stem cell boost and CD45RO + memory T-cell add-back as a successful salvage treatment for poor graft function unresponsive to eltrombopag, following a second allogenic HSCT.

  • Authors : Ramanathan S; Department of Paediatric Haematopoietic Stem Cell Transplant, Great North Children's Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, UK.; Department of Paediatric and Adolescent Haematology and Oncology, Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Subjects: Hydrazines*/Hydrazines*/Hydrazines*/therapeutic use ; Benzoates*/Benzoates*/Benzoates*/therapeutic use ; Pyrazoles*/Pyrazoles*/Pyrazoles*/therapeutic use

  • Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Oct; Vol. 71 (10), pp. e31203. Date of Electronic Publication: 2024 Jul 15.Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Report

Successful use of eltrombopag in ITP post-splenectomy despite pre-splenectomy failure.

  • Authors : Budhu G; Joe DiMaggio Children's Hospital, Hollywood, Florida, USA.; Cauff B

Subjects: Benzoates*/Benzoates*/Benzoates*/therapeutic use ; Hydrazines*/Hydrazines*/Hydrazines*/therapeutic use ; Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/drug therapy

  • Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Oct; Vol. 71 (10), pp. e31187. Date of Electronic Publication: 2024 Jul 08.Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study.

  • Authors : Cooper N; Imperial College Healthcare NHS Trust, London, UK.; Scully M

Subjects: Receptors, Thrombopoietin*/Receptors, Thrombopoietin*/Receptors, Thrombopoietin*/agonists ; Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/therapeutic use ; Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/adverse effects

  • Source: British journal of haematology [Br J Haematol] 2024 Jun; Vol. 204 (6), pp. 2442-2452. Date of Electronic Publication: 2024 Mar 01.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  671 results for ""Benzoates""